Sign inJoin waitlistJoin the waitlist

Jason Molitoris

Radiology / Radiation Oncology · Maryland Proton Treatment Center

Credentials: · · ·

History

Radiation Oncology
Univ of Maryland Sch of Med
2014–2018
2013–2014
Case Western Reserve University School of Medicine
2009–2013
The College of William and Mary
2001–2005

Research

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
Journal of Clinical Oncology · 2022 · 230 citations
Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
International journal of radiation oncology · 2017 · 167 citations
Induction of Ca²+-driven apoptosis in chronic lymphocytic leukemia cells by peptide-mediated disruption of Bcl-2-IP3 receptor interaction
Blood · 2011 · 109 citations

Matthew Ferris
23 papers
William Regine
20 papers
Ranee Mehra
18 papers
CS
Charles Simone
16 papers
Phuoc Tran
16 papers
Mark Mishra
14 papers
Kyle Hatten
13 papers
Zaker Rana
12 papers · 1 as a resident
JS
James Snider
11 papers · 4 as a resident
Matthew Witek
11 papers
Elizabeth Nichols
10 papers
Gregory Alexander
10 papers · 10 as a resident

Clinical trials

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer
Principal investigator · Recruiting · Phase 1
University of Maryland, Baltimore
2024–2028
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Principal investigator · Recruiting · Phase 2
University of Maryland, Baltimore
2024–2030
Hyperthermia Treatment Added to Chemotherapy Standard of Care for Pancreatic Tumors
Principal investigator · Unknown
NeoTherma Oncology
2023–2024
Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)
Principal investigator · Active not recruiting · Phase 1, Phase 2
University of Maryland, Baltimore
2019–2026